Keisha Sullivan, DO
Sleep Medicine · Leesburg, VANPI 1437545720
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (37.5%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by ZOLL Respicardia, Inc. at 36.8% of the total. Reporting peaked in 2022 at $1,235 and has fallen 98.1% since, to $23 in 2023.
Across 26 payments — averaging $60.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ZOLL Respicardia, Inc.$575
- Jazz Pharmaceuticals Inc.$414
- Resmed Corp$267
- Inspire Medical Systems, Inc.$133
- Harmony Biosciences LLC$45
- Eisai Inc.$32
- plus $98 from 5 others
What the payments were for
- Speaking & faculty fees$25016%
- Travel & lodging$57537%
- Food & beverage$58738%
- Education$15210%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ZOLL Respicardia, Inc. | 1 | $575 |
| Jazz Pharmaceuticals Inc. | 13 | $414 |
| Resmed Corp | 2 | $267 |
| Inspire Medical Systems, Inc. | 1 | $133 |
| Harmony Biosciences LLC | 2 | $45 |
| Eisai Inc. | 2 | $32 |
| AbbVie | 1 | $24 |
| Paratek Pharmaceuticals, Inc. | 1 | $24 |
| Idorsia Pharmaceuticals US Inc | 1 | $23 |
| Portola Pharmaceuticals, LLC | 1 | $16 |
| Mylan Specialty L.p. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,564 in reported general payments places this provider in the 55th percentile of 74 sleep medicine providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Modafinil | 14 | $447 |
| Gabapentin | 24 | $326 |
| Zaleplon | 23 | $309 |
| Quetiapine Fumarate | 15 | $145 |
| Zolpidem Tartrate | 15 | $106 |
Paid to pharmacies, not to this prescriber.
Other sleep medicine in Leesburg
- Marc RaphaelsonLeesburg$47K
- Shahriar ShahzeidiLeesburg$27K
- Swathi CharyaLeesburg$3K
- Sean RotoloLeesburg$3K
- Jessica RiggsLeesburg$3K
- Charu SabharwalLeesburg$2K
- James TomkinsonLeesburg$2K
- Patricia Jimenez GuzmanLeesburg$2K
- Hwan KimLeesburg$2K
- Pushkar DeshpandeLeesburg$913
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.